Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 8-K Event Executive or director change
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Grant or award Chief Operating Officer acquired 50,000 shares (grant or award)
  5. 4 Open-market buy Chief Financial Officer bought 3,700 shares at $13.42 ($49,668)
  6. 4 Open-market sale President & CEO sold 31,054 shares at $13.56 ($421,229)
  7. 8-K Event Executive or director change · Shareholder vote results
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 4 Grant or award Chief Operating Officer acquired 20,000 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
  14. 4 Grant or award Chief Scientific Officer acquired 20,000 shares (grant or award)
  15. DEFA14A Proxy Proxy Materials
  16. DEF 14A Proxy Proxy Statement
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief Scientific Officer sold 114,240 shares at $16.25 ($1,856,263)
  19. 4 Open-market sale Chief Operating Officer sold 26,649 shares at an average $15.46 ($412,065)
  20. 10-K Report Annual Report

Page 18 of 47 · 923 filings